{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:56:02Z","timestamp":1794048962622,"version":"4.8.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Recent hypertension guidelines differ in their recommendations on managing hypertension and associated cardiovascular risk. In this review, we highlight the key similarities and discrepancies among the recently published American College of Cardiology\/American Heart Association (ACC\/AHA), European Society of Cardiology (ESC), and European and International Society of Hypertension (ESH and ISH) hypertension guidelines. Despite differences in the definition of hypertension, all guidelines reflect a general trend towards earlier intervention and more stringent blood pressure (BP) targets, particularly for individuals at high cardiovascular risk. They align on lifestyle recommendations, such as dietary modification and physical activity, and advocate for combination therapy with a target BP of &amp;lt;130\/80\u2005mmHg if the risk is sufficiently high and treatment well tolerated. However, notable differences exist in treatment thresholds and BP targets for elderly individuals, as well as in the classification of hypertension phenotypes in younger patients. There are few discrepancies in recommended treatment classes, with all guidelines endorsing angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, and thiazide-type diuretics as first-line therapy. Knowledge gaps remain regarding optimal BP thresholds and targets across sex, age, and ethnic groups. Additional uncertainties include the clinical utility of intermediate outcomes in cardiovascular risk assessment, the long-term impact of life-course approaches to prevention, and the role of novel therapeutic agents. Emerging concerns such as climate change and air pollution also warrant further investigation for their potential effects on hypertension and cardiovascular risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay summary<\/jats:title>\n                    <jats:p>Guidelines are important tools to help clinicians make treatment decisions. For the management of hypertension, different guidelines have been released in recent years. Being the most important risk factor worldwide and with its burden still increasing, management of hypertension remains a challenge. This is especially true for low- and middle-income countries where hypertension awareness, treatment, and control rates are still low. To help clinicians make informed decisions, we have compared the most important hypertension guidelines that have appeared in the past 10 years and summarized their most important recommendations.<\/jats:p>\n                    <jats:p>Key findings are that:All recent hypertension guidelines advocate earlier intervention and more stringent blood pressure targets and promote a healthy lifestyleGuidelines differ in their definitions of hypertension, treatment thresholds and blood pressure targets for elderly individuals.<\/jats:p>\n                    <jats:p>Important knowledge gaps remain regarding optimal blood pressure thresholds and targets across sex, age, and ethnic groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf610","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:28:12Z","timestamp":1758540492000},"page":"1033-1044","source":"Crossref","is-referenced-by-count":3,"title":["Targets for treatment and optimal strategies for managing hypertension in 2025: indications for clinical practice from recent hypertension guidelines"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0943-4393","authenticated-orcid":false,"given":"Bert-Jan H","family":"van den Born","sequence":"first","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences and Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC , Meibergdreef 9, Amsterdam 1105 AZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-9996","authenticated-orcid":false,"given":"Theodora","family":"Bejan-Angoulvant","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Regional University Hospital Centre Tours and University of Tours , Tours ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4657-9172","authenticated-orcid":false,"given":"Martino F","family":"Pengo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Istituto Auxologico Italiano and Department of Medicine and Surgery, University of Milano-Bicocca , Milan ,","place":["Italy"]},{"name":"Department of Cardiology, University of Milano-Bicocca, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-549X","authenticated-orcid":false,"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center and Cardiovascular Research Institute Basel (CRIB), University Heart Center, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-8892","authenticated-orcid":false,"given":"Isabella","family":"Sudano","sequence":"additional","affiliation":[{"name":"University Heart Center Zurich, Department of Cardiology, University Hospital Zurich and University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-4205","authenticated-orcid":false,"given":"Henner","family":"Hanssen","sequence":"additional","affiliation":[{"name":"Division Sport and Exercise Medicine, Department of Sport, Exercise and Health, University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-7439","authenticated-orcid":false,"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Istituto Auxologico Italiano and Department of Medicine and Surgery, University of Milano-Bicocca , Milan ,","place":["Italy"]},{"name":"Department of Cardiology, University of Milano-Bicocca, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"2026051513430459600_zwaf610-B1","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","journal-title":"Lancet"},{"key":"2026051513430459600_zwaf610-B2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"key":"2026051513430459600_zwaf610-B3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension","volume":"18","author":"Zhou","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026051513430459600_zwaf610-B4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurjpc\/zwad262","article-title":"Worldwide trends in mortality for hypertensive heart disease from 1990 to 2019 with projection to 2034: data from the Global Burden of Disease 2019 study","volume":"31","author":"Lu","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026051513430459600_zwaf610-B5","first-page":"e114","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"152","author":"Writing Committee Members*","year":"2025","journal-title":"Circulation"},{"key":"2026051513430459600_zwaf610-B6","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026051513430459600_zwaf610-B7","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2026051513430459600_zwaf610-B8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 international society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41569-025-01187-2","article-title":"European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice","volume":"22","author":"Lauder","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"2026051513430459600_zwaf610-B10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.121.055177","article-title":"Thresholds for hypertension definition, treatment initiation, and treatment targets: recent guidelines at a glance","volume":"146","author":"Vidal-Petiot","year":"2022","journal-title":"Circulation"},{"key":"2026051513430459600_zwaf610-B11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential US population impact of the 2017 ACC\/AHA high blood pressure guideline","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation"},{"key":"2026051513430459600_zwaf610-B12","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"2026051513430459600_zwaf610-B14","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"2026051513430459600_zwaf610-B15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051513430459600_zwaf610-B16","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","author":"SCORE2-OP working group and ESC Cardiovascular risk collaboration","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051513430459600_zwaf610-B17","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1001\/jama.2018.16501","article-title":"Association of blood pressure classification in Korean young adults according to the 2017 American College of Cardiology\/American Heart Association Guidelines with subsequent cardiovascular disease events","volume":"320","author":"Son","year":"2018","journal-title":"JAMA"},{"key":"2026051513430459600_zwaf610-B18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/HJH.0000000000001233","article-title":"Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis","volume":"35","author":"Hirakawa","year":"2017","journal-title":"J Hypertens"},{"key":"2026051513430459600_zwaf610-B19","doi-asserted-by":"crossref","first-page":"e004152","DOI":"10.1161\/JAHA.116.004152","article-title":"Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network)","volume":"6","author":"L\u00f8nnebakken","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026051513430459600_zwaf610-B20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/CIRCRESAHA.121.318061","article-title":"Arterial stiffness and cardiovascular risk in hypertension","volume":"128","author":"Boutouyrie","year":"2021","journal-title":"Circ Res"},{"key":"2026051513430459600_zwaf610-B21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/HYPERTENSIONAHA.111.00430","article-title":"High blood pressure and cerebral white matter lesion progression in the general population","volume":"61","author":"Verhaaren","year":"2013","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.118.12191","article-title":"Prevalence of apparent treatment-resistant hypertension in the United States","volume":"73","author":"Carey","year":"2019","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(24)01405-3","article-title":"General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7\u00b75 million participants","volume":"404","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","journal-title":"Lancet"},{"key":"2026051513430459600_zwaf610-B24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2026051513430459600_zwaf610-B25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"2026051513430459600_zwaf610-B26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/HJH.0b013e3283544669","article-title":"The impact of physical activity on mortality in patients with high blood pressure: a systematic review","volume":"30","author":"Rossi","year":"2012","journal-title":"J Hypertens"},{"key":"2026051513430459600_zwaf610-B27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/bjsports-2023-107743","article-title":"Is isometric exercise training the best FIT for exercise prescription in the prevention and treatment of arterial hypertension?","volume":"58","author":"Hanssen","year":"2024","journal-title":"Br J Sports Med"},{"key":"2026051513430459600_zwaf610-B28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurjpc\/zwaa141","article-title":"Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on Hypertension","volume":"29","author":"Hanssen","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026051513430459600_zwaf610-B29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/eurjpc\/zwac202","article-title":"Lifestyle recommendations as treatment for arterial hypertension: a time to review","volume":"30","author":"Hanssen","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026051513430459600_zwaf610-B30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/eurheartj\/ehr007","article-title":"Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies","volume":"32","author":"Cappuccio","year":"2011","journal-title":"Eur Heart J"},{"key":"2026051513430459600_zwaf610-B31","doi-asserted-by":"crossref","first-page":"2400837","DOI":"10.1183\/13993003.00837-2024","article-title":"Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis","volume":"65","author":"Pengo","year":"2024","journal-title":"Eur Respir J"},{"key":"2026051513430459600_zwaf610-B32","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1038\/s41598-024-55724-z","article-title":"The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function","volume":"14","author":"Wajdlich","year":"2024","journal-title":"Sci Rep"},{"key":"2026051513430459600_zwaf610-B33","doi-asserted-by":"crossref","first-page":"102789","DOI":"10.1016\/j.eclinm.2024.102789","article-title":"GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity","volume":"75","author":"Jarade","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026051513430459600_zwaf610-B34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"2026051513430459600_zwaf610-B35","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.117.032130","article-title":"Effects of bariatric surgery in obese patients with hypertension","volume":"137","author":"Schiavon","year":"2018","journal-title":"Circulation"},{"key":"2026051513430459600_zwaf610-B36","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"2026051513430459600_zwaf610-B37","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.122.19020","article-title":"Individualized beta-blocker treatment for high blood pressure dictated by medical comorbidities: indications beyond the 2018 European Society of Cardiology\/European Society of Hypertension Guidelines","volume":"79","author":"Mancia","year":"2022","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B38","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"2026051513430459600_zwaf610-B39","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(17)30754-7","article-title":"Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials","volume":"389","author":"B\u00f6hm","year":"2017","journal-title":"Lancet"},{"key":"2026051513430459600_zwaf610-B40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"key":"2026051513430459600_zwaf610-B41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels\u2014updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"2026051513430459600_zwaf610-B42","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2026051513430459600_zwaf610-B43","first-page":"CD004349","article-title":"Blood pressure targets in adults with hypertension","volume":"12","author":"Arguedas","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051513430459600_zwaf610-B44","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/CIRCULATIONAHA.117.030342","article-title":"J curve in patients randomly assigned to different systolic blood pressure targets: an experimental approach to an observational paradigm","volume":"136","author":"Kalkman","year":"2017","journal-title":"Circulation"},{"key":"2026051513430459600_zwaf610-B45","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","journal-title":"Lancet"},{"key":"2026051513430459600_zwaf610-B46","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/HYPERTENSIONAHA.122.18732","article-title":"Noise and air pollution as risk factors for hypertension: part I\u2014epidemiology","volume":"80","author":"Hahad","year":"2023","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B47","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/HYPERTENSIONAHA.122.19494","article-title":"Seasonal variation in day-by-day home blood pressure variability and effect on cardiovascular disease incidence","volume":"79","author":"Narita","year":"2022","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B48","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/HYPERTENSIONAHA.123.20617","article-title":"Noise and air pollution as risk factors for hypertension: part II-pathophysiologic insight","volume":"80","author":"Hahad","year":"2023","journal-title":"Hypertension"},{"key":"2026051513430459600_zwaf610-B49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/HJH.0000000000003363","article-title":"Blood pressure variability: methodological aspects, clinical relevance and practical indications for management\u2014a European Society of Hypertension position paper \u2217","volume":"41","author":"Parati","year":"2023","journal-title":"J Hypertens"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf610\/64352171\/zwaf610.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/7\/1033\/64352171\/zwaf610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/7\/1033\/64352171\/zwaf610.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:43:13Z","timestamp":1778866993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/7\/1033\/8262114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,9,23]]},"published-print":{"date-parts":[[2026,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf610","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2025,9,23]]}}}